High levels of Crohn's disease-associated anti-microbial antibodies are present and independent of colitis in chronic granulomatous disease

Clinical Immunology

Volumn 138, Issue 1, 2011, Pages 14-22

  Yu, Joyce E ^a   De Ravin, Suk See ^b   Uzel, Gulbu ^b   Landers, Carol ^c   Targan, Stephan ^c   Malech, Harry L ^b   Holland, Steven M ^b   Cao, Wenqing ^a   Harpaz, Noam ^a   Mayer, Lloyd ^a   Cunningham Rundles Charlotte, C ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chronic granulomatous disease; Colitis; Hyper IgE Syndrome; Inflammatory bowel disease; Innate immunity; Serum antimicrobial antibodies

Indexed keywords

ANTIBODY; FLAGELLIN ANTIBODY; I2 ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFLIXIMAB; OUTER MEMBRANE PORIN ANTIBODY; PERINUCLEAR NEUTROPHIL CYTOPLASMIC ANTIBODY; SACCHAROMYCES CEREVISIAE ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ARTICLE; CHILD; CHRONIC GRANULOMATOUS DISEASE; COLITIS; COLON BIOPSY; CROHN DISEASE; FEMALE; HUMAN; HUMAN TISSUE; HYPER IGE SYNDROME; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AGING; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, BACTERIAL; ANTIBODIES, FUNGAL; CHILD; CHILD, PRESCHOOL; COLITIS; CROHN DISEASE; FEMALE; FLAGELLIN; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; IMMUNITY, INNATE; JOB'S SYNDROME; MALE; MIDDLE AGED; PORINS; PSEUDOMONAS FLUORESCENS; SACCHAROMYCES CEREVISIAE; YOUNG ADULT;

EID: 78651352892     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2010.08.003     Document Type: Article

References (63)

1. Holland S.M. Chronic granulomatous disease. Clin. Rev. Allergy Immunol. 2010, 38:3-10.
2. Malech H.L., Hickstein D.D. Genetics, biology and clinical management of myeloid cell primary immune deficiencies: chronic granulomatous disease and leukocyte adhesion deficiency. Curr. Opin. Hematol. 2007, 14:29-36.
3. Yu G., Hong D.K., Dionis K.Y., Rae J., Heyworth P.G., Curnutte J.T., Lewis D.B. Focus on FOCIS: the continuing diagnostic challenge of autosomal recessive chronic granulomatous disease. Clin. Immunol. 2008, 128:117-126.
4. Jones L.B., McGrogan P., Flood T.J., Gennery A.R., Morton L., Thrasher A., Goldblatt D., Parker L., Cant A.J. Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry. Clin. Exp. Immunol. 2008, 152:211-218.
5. Matute J.D., Arias A.A., Wright N.A., Wrobel I., Waterhouse C.C., Li X.J., Marchal C.C., Stull N.D., Lewis D.B., Steele M., Kellner J.D., Yu W., Meroueh S.O., Nauseef W.M., Dinauer M.C. A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity. Blood 2009, 114:3309-3315.
6. Winkelstein J.A., Marino M.C., Johnston R.B., Boyle J., Curnutte J., Gallin J.I., Malech H.L., Holland S.M., Ochs H., Quie P., Buckley R.H., Foster C.B., Chanock S.J., Dickler H. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 2000, 79:155-169.
7. Eppinger T.M., Greenberger P.A., White D.A., Brown A.E., Cunningham-Rundles C. Sensitization to Aspergillus species in the congenital neutrophil disorders chronic granulomatous disease and hyper-IgE syndrome. J. Allergy Clin. Immunol. 1999, 104:1265-1272.
8. Schappi M.G., Jaquet V., Belli D.C., Krause K.H. Hyperinflammation in chronic granulomatous disease and anti-inflammatory role of the phagocyte NADPH oxidase. Semin. Immunopathol. 2008, 30:255-271.
9. De Ravin S.S., Naumann N., Cowen E.W., Friend J., Hilligoss D., Marquesen M., Balow J.E., Barron K.S., Turner M.L., Gallin J.I., Malech H.L. Chronic granulomatous disease as a risk factor for autoimmune disease. J. Allergy Clin. Immunol. 2008, 122:1097-1103.
10. Arimura Y., Goto A., Yamashita K., Endo T., Ikeda H., Tanaka K., Tsutsumi H., Shinomura Y., Imai K. Intractable colitis associated with chronic granulomatous disease. J. Med. Microbiol. 2006, 55:1587-1590.
11. Barton L.L., Moussa S.L., Villar R.G., Hulett R.L. Gastrointestinal complications of chronic granulomatous disease: case report and literature review. Clin. Pediatr. (Phila) 1998, 37:231-236.
12. Hoare S., Walsh J.E., Eastham E., Abinun M.A., Cant A.J. Abnormal technetium labelled white cell scan in the colitis of chronic granulomatous disease. Arch. Dis. Child. 1997, 77:50-51.
13. Huang J.S., Noack D., Rae J., Ellis B.A., Newbury R., Pong A.L., Lavine J.E., Curnutte J.T., Bastian J. Chronic granulomatous disease caused by a deficiency in p47(phox) mimicking Crohn's disease. Clin. Gastroenterol. Hepatol. 2004, 2:690-695.
14. Levine S., Smith V.V., Malone M., Sebire N.J. Histopathological features of chronic granulomatous disease (CGD) in childhood. Histopathology 2005, 47:508-516.
15. Marciano B.E., Rosenzweig S.D., Kleiner D.E., Anderson V.L., Darnell D.N., Anaya-O'Brien S., Hilligoss D.M., Malech H.L., Gallin J.I., Holland S.M. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics 2004, 114:462-468.
16. Schappi M.G., Smith V.V., Goldblatt D., Lindley K.J., Milla P.J. Colitis in chronic granulomatous disease. Arch. Dis. Child. 2001, 84:147-151.
17. Gopal L., Forbes J., Uzel G., Holland S.M., Heller T. Gastrointestinal fistulae in chronic granulomatous disease. Am. J. Gastroenterol. 2009, 104:2112-2113.
18. Marks D.J., Miyagi K., Rahman F.Z., Novelli M., Bloom S.L., Segal A.W. Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn's disease. Am. J. Gastroenterol. 2009, 104:117-124.
19. Schappi M.G., Klein N.J., Lindley K.J., Rampling D., Smith V.V., Goldblatt D., Milla P.J. The nature of colitis in chronic granulomatous disease. J. Pediatr. Gastroenterol. Nutr. 2003, 36:623-631.
20. Hugot J.P., Cho J.H. Update on genetics of inflammatory bowel disease. Curr. Opin. Gastroenterol. 2002, 18:410-415.
21. Rioux J.D., Xavier R.J., Taylor K.D., Silverberg M.S., Goyette P., Huett A., Green T., Kuballa P., Barmada M.M., Datta L.W., Shugart Y.Y., Griffiths A.M., Targan S.R., Ippoliti A.F., Bernard E.J., Mei L., Nicolae D.L., Regueiro M., Schumm L.P., Steinhart A.H., Rotter J.I., Duerr R.H., Cho J.H., Daly M.J., Brant S.R. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet. 2007, 39:596-604.
22. Beaven S.W., Abreu M.T. Biomarkers in inflammatory bowel disease. Curr. Opin. Gastroenterol. 2004, 20:318-327.
23. Dotan N., Altstock R.T., Schwarz M., Dukler A. Anti-glycan antibodies as biomarkers for diagnosis and prognosis. Lupus 2006, 15:442-450.
24. Targan S.R., Karp L.C. Inflammatory bowel disease diagnosis, evaluation and classification: state-of-the art approach. Curr. Opin. Gastroenterol. 2007, 23:390-394.
25. Landers C.J., Cohavy O., Misra R., Yang H., Lin Y.C., Braun J., Targan S.R. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology 2002, 123:689-699.
26. Reumaux D., Sendid B., Poulain D., Duthilleul P., Dewit O., Colombel J.F. Serological markers in inflammatory bowel diseases. Best Pract. Res. Clin. Gastroenterol. 2003, 17:19-35.
27. Targan S.R., Karp L.C. Defects in mucosal immunity leading to ulcerative colitis. Immunol. Rev. 2005, 206:296-305.
28. Wehkamp J., Stange E.F. A new look at Crohn's disease: breakdown of the mucosal antibacterial defense. Ann. N. Y. Acad. Sci. 2006, 1072:321-331.
29. Vowells S.J., Sekhsaria S., Malech H.L., Shalit M., Fleisher T.A. Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. J. Immunol. Methods 1995, 178:89-97.
30. Cohavy O., Bruckner D., Gordon L.K., Misra R., Wei B., Eggena M.E., Targan S.R., Braun J. Colonic bacteria express an ulcerative colitis pANCA-related protein epitope. Infect. Immun. 2000, 68:1542-1548.
31. Lodes M.J., Cong Y., Elson C.O., Mohamath R., Landers C.J., Targan S.R., Fort M., Hershberg R.M. Bacterial flagellin is a dominant antigen in Crohn disease. J. Clin. Invest. 2004, 113:1296-1306.
32. Saxon A., Shanahan F., Landers C., Ganz T., Targan S. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J. Allergy Clin. Immunol. 1990, 86:202-210.
33. Sendid B., Colombel J.F., Jacquinot P.M., Faille C., Fruit J., Cortot A., Lucidarme D., Camus D., Poulain D. Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clin. Diagn. Lab. Immunol. 1996, 3:219-226.
34. Sutton C.L., Kim J., Yamane A., Dalwadi H., Wei B., Landers C., Targan S.R., Braun J. Identification of a novel bacterial sequence associated with Crohn's disease. Gastroenterology 2000, 119:23-31.
35. D'Agata I.D., Paradis K., Chad Z., Bonny Y., Seidman E. Leucocyte adhesion deficiency presenting as a chronic ileocolitis. Gut 1996, 39:605-608.
36. Sanderson I.R., Bisset W.M., Milla P.J., Leonard J.V. Chronic inflammatory bowel disease in glycogen storage disease type 1B. J. Inherit. Metab. Dis. 1991, 14:771-776.
37. Yamaguchi T., Ihara K., Matsumoto T., Tsutsumi Y., Nomura A., Ohga S., Hara T. Inflammatory bowel disease-like colitis in glycogen storage disease type 1b. Inflamm. Bowel Dis. 2001, 7:128-132.
38. Hussain N., Quezado M., Huizing M., Geho D., White J.G., Gahl W., Mannon P. Intestinal disease in Hermansky-Pudlak syndrome: occurrence of colitis and relation to genotype. Clin. Gastroenterol. Hepatol. 2006, 4:73-80.
39. Seger R.A. Modern management of chronic granulomatous disease. Br. J. Haematol. 2008, 140:255-266.
40. Nenci A., Becker C., Wullaert A., Gareus R., van Loo G., Danese S., Huth M., Nikolaev A., Neufert C., Madison B., Gumucio D., Neurath M.F., Pasparakis M. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 2007, 446:557-561.
41. Pai S.Y., Levy O., Jabara H.H., Glickman J.N., Stoler-Barak L., Sachs J., Nurko S., Orange J.S., Geha R.S. Allogeneic transplantation successfully corrects immune defects, but not susceptibility to colitis, in a patient with nuclear factor-kappaB essential modulator deficiency. J. Allergy Clin. Immunol. 2008, 122:1113-1118. (e1).
42. Permaul P., Narla A., Hornick J.L., Pai S.Y. Allogeneic hematopoietic stem cell transplantation for X-linked ectodermal dysplasia and immunodeficiency: case report and review of outcomes. Immunol. Res. 2009, 44:89-98.
43. Agarwal S., Mayer L. Gastrointestinal manifestations in primary immune disorders. Inflamm. Bowel Dis. 2010, 16:703-711.
44. Daniels J.A., Lederman H.M., Maitra A., Montgomery E.A. Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review. Am. J. Surg. Pathol. 2007, 31:1800-1812.
45. Couper R., Kapelushnik J., Griffiths A.M. Neutrophil dysfunction in glycogen storage disease Ib: association with Crohn's-like colitis. Gastroenterology 1991, 100:549-554.
46. Uzel G., Kleiner D.E., Kuhns D.B., Holland S.M. Dysfunctional LAD-1 neutrophils and colitis. Gastroenterology 2001, 121:958-964.
47. Smith A.M., Rahman F.Z., Hayee B., Graham S.J., Marks D.J., Sewell G.W., Palmer C.D., Wilde J., Foxwell B.M., Gloger I.S., Sweeting T., Marsh M., Walker A.P., Bloom S.L., Segal A.W. Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease. J. Exp. Med. 2009, 206:1883-1897.
48. Rahman F.Z., Hayee B., Chee R., Segal A.W., Smith A.M. Impaired macrophage function following bacterial stimulation in chronic granulomatous disease. Immunology 2009, 128:253-259.
49. Mow W.S., Vasiliauskas E.A., Lin Y.C., Fleshner P.R., Papadakis K.A., Taylor K.D., Landers C.J., Abreu-Martin M.T., Rotter J.I., Yang H., Targan S.R. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology 2004, 126:414-424.
50. Slack E., Hapfelmeier S., Stecher B., Velykoredko Y., Stoel M., Lawson M.A., Geuking M.B., Beutler B., Tedder T.F., Hardt W.D., Bercik P., Verdu E.F., McCoy K.D., Macpherson A.J. Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science 2009, 325:617-620.
51. Henckaerts L., Pierik M., Joossens M., Ferrante M., Rutgeerts P., Vermeire S. Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease. Gut 2007, 56:1536-1542.
52. Dann S.M., Eckmann L. Innate immune defenses in the intestinal tract. Curr. Opin. Gastroenterol. 2007, 23:115-120.
53. Devlin S.M., Yang H., Ippoliti A., Taylor K.D., Landers C.J., Su X., Abreu M.T., Papadakis K.A., Vasiliauskas E.A., Melmed G.Y., Fleshner P.R., Mei L., Rotter J.I., Targan S.R. NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relatives. Gastroenterology 2007, 132:576-586.
54. Takedatsu H., Taylor K.D., Mei L., McGovern D.P., Landers C.J., Gonsky R., Cong Y., Vasiliauskas E.A., Ippoliti A., Elson C.O., Rotter J.I., Targan S.R. Linkage of Crohn's disease-related serological phenotypes: NFKB1 haplotypes are associated with anti-CBir1 and ASCA, and show reduced NF-kappaB activation. Gut 2009, 58:60-67.
55. Mei L., Targan S.R., Landers C.J., Dutridge D., Ippoliti A., Vasiliauskas E.A., Papadakis K.A., Fleshner P.R., Rotter J.I., Yang H. Familial expression of anti-Escherichia coli outer membrane porin C in relatives of patients with Crohn's disease. Gastroenterology 2006, 130:1078-1085.
56. Holland S.M., DeLeo F.R., Elloumi H.Z., Hsu A.P., Uzel G., Brodsky N., Freeman A.F., Demidowich A., Davis J., Turner M.L., Anderson V.L., Darnell D.N., Welch P.A., Kuhns D.B., Frucht D.M., Malech H.L., Gallin J.I., Kobayashi S.D., Whitney A.R., Voyich J.M., Musser J.M., Woellner C., Schaffer A.A., Puck J.M., Grimbacher B. STAT3 mutations in the hyper-IgE syndrome. N. Engl. J. Med. 2007, 357:1608-1619.
57. Avery D.T., Deenick E.K., Ma C.S., Suryani S., Simpson N., Chew G.Y., Chan T.D., Palendira U., Bustamante J., Boisson-Dupuis S., Choo S., Bleasel K.E., Peake J., King C., French M.A., Engelhard D., Al-Hajjar S., Al-Muhsen S., Magdorf K., Roesler J., Arkwright P.D., Hissaria P., Riminton D.S., Wong M., Brink R., Fulcher D.A., Casanova J.L., Cook M.C., Tangye S.G. B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans. J. Exp. Med. 2010, 207:155-171.
58. Cannioto Z., Berti I., Martelossi S., Bruno I., Giurici N., Crovella S., Ventura A. IBD and IBD mimicking enterocolitis in children younger than 2years of age. Eur. J. Pediatr. 2009, 168:149-155.
59. Desir B., Amre D.K., Lu S.E., Ohman-Strickland P., Dubinsky M., Fisher R., Seidman E.G. Utility of serum antibodies in determining clinical course in pediatric Crohn's disease. Clin. Gastroenterol. Hepatol. 2004, 2:139-146.
60. Dubinsky M. Special issues in pediatric inflammatory bowel disease. World J. Gastroenterol. 2008, 14:413-420.
61. Hoffenberg E.J., Fidanza S., Sauaia A. Serologic testing for inflammatory bowel disease. J. Pediatr. 1999, 134:447-452.
62. Zholudev A., Zurakowski D., Young W., Leichtner A., Bousvaros A. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Am. J. Gastroenterol. 2004, 99:2235-2241.
63. Markowitz J., Kugathasan S., Dubinsky M., Mei L., Crandall W., Leleiko N., Oliva-Hemker M., Rosh J., Evans J., Mack D., Otley A., Pfefferkorn M., Bahar R., Vasiliauskas E., Wahbeh G., Silber G., Quiros J.A., Wrobel I., Nebel J., Landers C., Picornell Y., Targan S., Lerer T., Hyams J. Age of diagnosis influences serologic responses in children with Crohn's disease: a possible clue to etiology?. Inflamm. Bowel Dis. 2010, 15:714-719.